Biology subjects

Torres, C. M.

Publications and source records attributed to Torres, C. M..

3 recordsLinked to original sources

bioRxiv2026

Type I Natural Killer T Cells Suppress Infection-Induced Hypercytokinemia via an IL-22-Dependent Mechanism

Severe infections can trigger systemic inflammatory response syndrome (SIRS), wherein excessive cytokine release generates a "cytokine storm" causing tissue damage, multi-organ failure, and death. Natural killer T (NKT) cells are innate-like lymphocytes that respond rapidly to infection and can either amplify or suppress inflammation. Distinct NKT subsets may have opposing roles in acute infection, but their specific contributions to hyperinflammation remain unclear. Using an intradermal murine Francisella tularensis LVS model of infection-induced cytokine storm, we demonstrate that type I NKT cells act as dominant suppressors of systemic hyperinflammation, whereas type II-enriched NKT cells confer limited protection. This immunoregulation occurs via secreted mediators rather than direct cytotoxicity or cell-cell contact. Notably, we identify IL-22 as a key type I NKT cell effector that suppresses pro-inflammatory cytokine levels. These findings define a novel IL-22-dependent type I NKT cell immunoregulatory axis that restrains pathological macrophage cytokine responses during severe bacterial infection.

immunology↗

bioRxiv2025

makeTCR: a Flexible Platform for Rapid, Scalable, Single-Step T Cell Receptor Synthesis

Personalised cell therapies utilising T cell receptors (TCRs) show tremendous clinical promise, though TCR synthesis and validation techniques lag behind our ability to sequence TCR repertoires. To address this gap, we developed makeTCR: a flexible modular, scalable TCR cloning system that enables single-step, 100% fidelity assembly of {beta} and {gamma}{delta} TCRs into commonly used expression vectors. By implementing cell-free manufacturing, makeTCR enables patient-derived TCRs to be functionally validated within 48 hours. We provide an open-source, easily extensible, web-based graphical platform that integrates existing tools to simplify and standardise the manufacture of TCRs across all scales of synthesis.

immunology↗

bioRxiv2023

A minimal physical model for curvotaxis driven by curved protein complexes at the cell's leading edge

Cells often migrate on curved surfaces inside the body, such as curved tissues, blood vessels or highly curved protrusions of other cells. Recent in-vitro experiments provide clear evidence that motile cells are affected by the curvature of the substrate on which they migrate, preferring certain curvatures to others, termed "curvotaxis". The origin and underlying mechanism that gives rise to this curvature sensitivity are not well understood. Here, we employ a "minimal cell" model which is composed of a vesicle that contains curved membrane protein complexes, that exert protrusive forces on the membrane (representing the pressure due to actin polymerization). This minimal-cell model gives rise to spontaneous emergence of a motile phenotype, driven by a lamellipodia-like leading edge. By systematically screening the behaviour of this model on different types of curved substrates (sinusoidal, cylinder and tube), we show that minimal ingredients and energy terms capture the experimental data. The model recovers the observed migration on the sinusoidal substrate, where cells move along the grooves (minima), while avoiding motion along the ridges. In addition, the model predicts the tendency of cells to migrate circumferentially on convex substrates and axially on concave ones. Both of these predictions are verified experimentally, on several cell types. Altogether, our results identify the minimization of membrane-substrate adhesion energy and binding energy between the membrane protein complexes as key players of curvotaxis in cell migration.

biophysics↗